Question 1

Does Brevan Howard Capital Management own IOVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Brevan Howard Capital Management holds 81,981 shares of IOVA (Iovance Biotherapeutics), worth $341,041.

Question 2

How many shares of IOVA does Brevan Howard Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Brevan Howard Capital Management holds 81,981 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is Brevan Howard Capital Management's IOVA position worth?

Accepted Answer

As of its Q2 2026 13F, Brevan Howard Capital Management's IOVA position is worth $341,041.

Question 4

Is Brevan Howard Capital Management buying or selling IOVA?

Accepted Answer

In Q2 2026, Brevan Howard Capital Management opened a new IOVA position of 81,981 shares.

Question 5

When did Brevan Howard Capital Management first buy IOVA?

Accepted Answer

Brevan Howard Capital Management first reported IOVA in its Q2 2022 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	81,981	—	$341,041	0.0%	$4.16	33
2026-Q1	Exited	0	-100.0%	$0	0.0%	$3.51	0
2025-Q4	Increased	525,519	+93.2%	$1.4M	0.0%	$2.73	40
2025-Q3	Decreased	271,967	-24.8%	$590,168	0.0%	$2.17	0
2025-Q2	Increased	361,803	+236.2%	$622,301	0.0%	$1.72	39
2025-Q1	Increased	107,615	+799.6%	$358,358	0.0%	$3.33	38
2024-Q4	Decreased	11,962	-64.9%	$88,519	0.0%	$7.40	0
2024-Q3	Increased	34,121	+43.5%	$320,396	0.0%	$9.39	32